Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Senseonics Holdings, Inc. (SENS)

0.7601   -0.086 (-10.16%) 03-22 13:09
Open: 0.8425 Pre. Close: 0.8461
High: 0.8492 Low: 0.76
Volume: 4,783,778 Market Cap: 365(M)

Technical analysis

as of: 2023-03-22 12:50:01 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.15     One year: 1.31
Support: Support1: 0.76    Support2: 0.63
Resistance: Resistance1: 0.98    Resistance2: 1.12
Pivot: 0.91
Moving Average: MA(5): 0.82     MA(20): 0.93
MA(100): 1.08     MA(250): 1.27
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 11     %D(3): 10
RSI: RSI(14): 30.3
52-week: High: 2.44  Low: 0.76
Average Vol(K): 3-Month: 2,723 (K)  10-Days: 4,811 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ SENS ] has closed above bottom band by 1.9%. Bollinger Bands are 60.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.86 - 0.86 0.86 - 0.87
Low: 0.81 - 0.81 0.81 - 0.81
Close: 0.84 - 0.85 0.85 - 0.85

Company Description

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Headline News

Tue, 21 Mar 2023
PHC Holdings Now Owns 15.41% of Senseonics - 24/7 Wall St.

Mon, 20 Mar 2023
DexCom Inc. stock rises Monday, outperforms market - MarketWatch

Mon, 20 Mar 2023
The Continuous Glucose Monitoring (CGM) Sensors Market ... - Digital Journal

Fri, 17 Mar 2023
DexCom Inc. stock outperforms competitors despite losses on the day - MarketWatch

Wed, 15 Mar 2023
Senseonics Holdings Inc earnings beat by $0.06, revenue topped ... -

Wed, 15 Mar 2023
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year ... - Business Wire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Outperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 446 (M)
Shares Float 316 (M)
% Held by Insiders 10.1 (%)
% Held by Institutions 31.3 (%)
Shares Short 75,530 (K)
Shares Short P.Month 76,920 (K)

Stock Financials

EPS -1.31
EPS Est Next Qtl -0.16
EPS Est This Year -0.55
EPS Est Next Year -0.64
Book Value (p.s.) -0.61
Profit Margin (%) 0
Operating Margin (%) -395.1
Return on Assets (ttm) -25.4
Return on Equity (ttm) 0
Qtrly Rev. Growth 360.5
Gross Profit (p.s.) -0.04
Sales Per Share 0.03
EBITDA (p.s.) -0.12
Qtrly Earnings Growth 0
Operating Cash Flow -53 (M)
Levered Free Cash Flow -35 (M)

Stock Valuations

PE Ratio -0.59
PEG Ratio -0.2
Price to Book value -1.28
Price to Sales 25.26
Price to Cash Flow -6.52

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.